ArticleJournal of ovarian research2026
Unraveling the role of lipid metabolism in polycystic ovary syndrome through multi-omics Mendelian randomization.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPolycystic ovary syndrome (PCOS) is increasingly recognized as a metabolic disorder, with dysregulated lipid metabolism emerging as a key factor in its pathogenesis. However, the precise mechanisms underlying this relationship remain unclear. We employed a summary data-based Mendelian randomization (SMR) approach to investigate the potential causal relationships between lipid metabolism-related genes and PCOS. First, we integrated PCOS genome-wide association study (GWAS) data from the Finngen_R11_E4_PCOS cohort with three layers of blood-based molecular quantitative trait loci (QTLs): methylation QTLs (mQTLs), expression QTLs (eQTLs), and protein QTLs (pQTLs). To ensure the robustness of the SMR signals, we performed the heterogeneity in dependent instruments (HEIDI) test to detect potential horizontal pleiotropy and conducted colocalization analysis to identify shared potential causal genetic variants. Findings were validated in two independent cohorts: Phenocode_265.4 and Felix. We then integrated mQTL and eQTL data to further dissect methylation-mediated gene expression regulation. Finally, we examined the expression profiles of key candidate genes using publicly available transcriptomic datasets from the Gene Expression Omnibus (GEO) database.
resultsSMR analysis in the discovery cohort identified 132 mQTLs (corresponding to 70 genes), 16 eQTLs, and 7 pQTLs associated with PCOS. Among these, 71 mQTLs (corresponding to 39 genes), 11 eQTLs, and 4 pQTLs were supported by strong colocalization evidence. Further validation in the Phenocode_265.4 and Felix cohorts confirmed the association of 13 mQTLs (corresponding to 7 genes) and 2 eQTLs with PCOS. Specifically, the associations of ACOX2 (cg22012981), GLIPR1 (cg01554451), and PIK3R3 (cg27584146) with PCOS were further supported by subsequent analyses. mQTL‑eQTL SMR analysis confirmed the negative regulatory effects of these methylation sites on the expression of their corresponding genes. Finally, transcriptomic data revealed upregulation of GLIPR1 and PIK3R3 in tissues from patients with PCOS.
conclusionThis study shows the association of lipid metabolism-related genes, particularly ACOX2, PIK3R3, and GLIPR1, with PCOS pathogenesis. These findings highlight them as candidates for further functional studies and potential future therapeutic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.